Credit Suisse’s Aerie Pharmaceuticals AERI Stock Holding History

Credit Suisse’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-15,000	Closed	-$288K	–	4390
2019 Q3	$288K	Hold	15,000	–	–	﹤0.01%	3719
2019 Q2	$443K	Buy	+15,000	New	+$578K	﹤0.01%	3477

Credit Suisse's AERI Position: Q4 2022 in Review

Credit Suisse sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 164,647 shares — an estimated $2.49M sold.

Credit Suisse first reported a position in AERI in Q1 2014 and held it in 34 quarters. The position peaked at $17.9M in Q1 2018. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

Credit Suisse reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Credit Suisse sold 164,647 Aerie Pharmaceuticals shares in Q4 2022, an estimated $2.49M.
Credit Suisse first reported a position in Aerie Pharmaceuticals in Q1 2014 and held it in 34 quarters.
Credit Suisse's Aerie Pharmaceuticals position peaked at $17.9M in Q1 2018.
0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Credit Suisse's 13F filing for Q4 2022, filed 13 Feb 2023.